1057.9000 12.50 (1.20%)
NSE Sep 19, 2025 15:31 PM
Volume: 67,984
 

1057.90
1.20%
ICICI Securities Limited
Vijaya Diagnostic Centre’s (Vijaya) Q4FY23 performance was driven by a steady 22.4% YoY growth in non-covid business, while covid business’ contribution fell to 1% (15% in Q4FY22). Overheads of new centres impacted EBITDA margin to a small extent though, at 40.6% in Q4, it continues to be better than that of most of listed peers.
Vijaya Diagnostic Centre Ltd. is trading above all available SMAs
More from Vijaya Diagnostic Centre Ltd.
Recommended